Posters
« Back
Investigating orthogonal in vitro analytical approaches to demonstrate bioequivalence (BE) of nasal suspension formulations
EP29025
Poster Title: Investigating orthogonal in vitro analytical approaches to demonstrate bioequivalence (BE) of nasal suspension formulations
Submitted on 28 Aug 2018
Author(s): Gonçalo Farias, Robert Price, William Ganley, Debbie Huck-Jones, Paul Kippax & Jagdeep Shur
Affiliations: University of Bath, Malvern Instruments Limited
This poster was presented at Drug Delivery to the Lungs conference
Poster Views: 488
View poster »


Poster Information
Abstract: Nasal suspension drug products consist of API particles suspended in an aqueous system in the presence of a range of different excipients.

For suspension nasal products, the API particle size is a key critical material attribute, which will affect emitted API particle size and regional deposition of API in the nose. In addition, the particle size of the API will affect the rate of dissolution and permeability at site of deposition in the nasal epithelium and thereby systemic exposure of the API from the nose.

The paucity of validated methods for characterizing API specific drug particle size distribution (PSD) in nasal formulations has resulted in limited understanding of the relationship between API PSD, regional deposition in the nasal cavity, dissolution, and absorption of the API from the nose.

Although PSD can be readily determined by a number of methods prior to formulation into a finished product, the primary challenge has been to determine the PSD of the drug substance in the finished nasal aqueous suspension products in the presence of undissolved excipients[3]. Excipients often exhibit a broad PSD and a substantial number of excipient particles may exist in the same size range as the drug substance, thus complicating drug substance particle size determination. Morphology-directed Raman Spectroscopy (MDRS) is a promising approach for characterizing particle size of API in aqueous nasal spray suspension formulations. Morphological filters are used to allow the detection of a statistically relevant number of API particles. This approach allows the chemical identification of API in situ within complex nasal formulations which can directly benefit the BE requirements for ANDAs.
Summary: Demonstration of a combination of dissolution testing and morphologically-directed Raman spectroscopy (MDRS®) of a nasal suspension was able to discriminate between differences in API particle size in nasal suspension formulations. The approach allowed characterization of particle size distribution of the API in the formulation facilitating comparative analysis of test and reference products to help determine bioequivalence of nasal suspensions formulations using in vitro methods.References: 1. Li BV et al. AAPS J 2013, 15:875–883.
2. Doub WH, et al. Pharm. Res. 2012, 29:3122–3130.
3. Doub WH, et al. Pharm. Res. 2007, 24:934–945.
4. Rygg A, et al. Pharm. Res. 2015:1–13.
5. Mitchell J, et al. AAPS PharmSciTech 2011, 12:965–988.
6. Sharpe SA, et al. Drug Dev Ind Pharm 2003, 29:1005–1012.
7. Shur J, http://ipacrs.org/assets/uploads/outputs/02_UoB_JS_Final_HOv2.pdf.
Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Etiological diagnostics of cardiomyopathies in the cardiology unit of the HUEH internal medicine department during the period from 8 January 2014 to 14 June 2014
*Axler JEAN PAUL; **Lesly Ed. ARCHER; *Raema Mimrod JEAN; *Gerald VERNELUS; *Rodolph MALEBRANCHE

Medical Student: Move over Stem Cells – Exosomes are Here! What are Exosomes & their role in Regenerative Medicine?
Amartej Singh Deol MD4 & Advisor: Shivinder S. Deol MD

Resident: NONHEALING ULCER THE NEED TO LOOK FURTHER
Briand Bounkeu MD; Ravi Shekarappa MD; La Toya Jackson DO, FAAFP; Chinedu Ivonye MD, FACP; Cristal Kudiwu MD

Striving for Equity in Surgical, Anesthesia, and Obstetric Research in Haiti: A Multi-Partner, International Research Training Collaboration
Dr. Jean Alouidor*, Dr. Frédéric Barau Déjean*, Dr. Louis-Franck Télémaque, Dr. Ronald Eveillard, Dr. Laëlle Mangurat, Dr. Isaac Martineau, Dr. Chartelin Jean Isaac, Dr. Darlène Rochelin Paultre, Carine Réveil Jean-Baptiste, Dr. Lucile Louis Riché, Dr. Jordan Pyda, Rolvix Patterson III, Dr. Blake Alkire, Dr. Eunice Dérivois-Mérisier (*Co-First Authors)

Projektstatus: Entwicklung einer konsensbasierten Therapieempfehlung für die PADOVAN-METHODE® in der Neurorehabilitation
Eisenmeier, Dimitri1; Ostermann, Thomas1; Vogel, Hannah1; Fetz, Katharina1